Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Apraclonidine hydrochloride (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanfacine (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanabenz (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methyldopa (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Central alpha-adrenoceptor agonist poisoning |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental clonidine poisoning |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional clonidine poisoning |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la clonidine d'intention indéterminée |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Central alpha-adrenoceptor agonist adverse reaction |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine adverse reaction |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine adverse reaction (disorder) |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lofexidine adverse reaction |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Central alpha-adrenoceptor agonist allergy |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine allergy |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to clonidine (finding) |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to lofexidine (finding) |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Central alpha-adrenoceptor agonist overdose |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clonidine overdose |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental clonidine overdose |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional clonidine overdose (disorder) |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de clonidine d'intention indéterminée |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 250micrograms m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 150micrograms/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine HCl [migraine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lofexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lofexidine hydrochloride 200 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing central alpha-adrenoceptor agonist |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing lofexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 0.1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 0.2mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 0.3mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine 2.5mg/unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine 7.5mg/unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 100mcg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine 4mg/patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine 0.1mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine 5mg patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorthalidone + clonidine hydrochloride 15mg/0.3mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clonidine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by clonidine |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clonidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine hydrochloride 1%/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine hydrochloride 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chlortalidone and clonidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 100mcg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 300micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine 1% intra-ocular solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Apraclonidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride 0.5mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lofexidine (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Central alpha-adrenoceptor agonist allergy |
Causative agent (attribute) |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lofexidine hydrochloride (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clonidine hydrochloride (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methyldopa anhydrous |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanfacine hydrochloride (substance) |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guanabenz acetate |
Is a |
False |
Substance with central alpha adrenergic receptor agonist mechanism of action |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|